Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H14N2O2S |
InChIKeyNZWTWRNHYZNWNW-UHFFFAOYSA-N |
CAS Registry444930-42-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 07 Mar 2012 |